Virginia Commonwealth University

What Virginia Commonwealth University does

Virginia Commonwealth University (VCU) is a public research university headquartered in Richmond, Virginia, operating across the Monroe Park and MCV campuses with a workforce of 10,000+ employees and offering more than 200 undergraduate, graduate, and professional degree and certificate programs. It is recognized by the National Science Foundation as a top-50 public research university, with research expenditures of $524 million and research funding of $568 million (doubled over five years), spanning biomedical engineering, cancer research, pharmaceutical development, semiconductor and nanomaterials (spintronic computing, nanomagnetic architectures), rare-earth separation, respiratory therapeutics, and genomic sequencing. VCU Health, the university's wholly owned academic medical system, delivers tertiary and quaternary care including transplant medicine (550+ transplants expected in 2025), specialized sickle cell care, and rare disease programs. Distribution is through on-campus instruction in Richmond, VCU Online, VCU Qatar, and VCU Health clinical sites.

VCU's revenue model combines six streams: tuition and fees (e.g., $12,850 in-state undergraduate tuition 2023-24), state appropriations from the Commonwealth of Virginia, federal and foundation research grants and contracts (NIH, NSF, Gates Foundation, VIPC, DoJ), clinical revenue from VCU Health, technology licensing to industry partners (notably Rocket One Inc. for nanomagnetic and spintronic AI memory technologies), and private philanthropy. Research funding is allocated across cancer therapeutics, AI accelerators, neuromodulation, wearable biosensors, and rare-earth processing. The university has demonstrated technology transfer outcomes including a $3 million Gates Foundation grant for neonatal respiratory distress treatment, $100,000+ in VIPC commercialization awards, an S824 synthetic protein spinout (BioRe-Element Technologies), and a flagship exclusive license to Rocket One Inc. for dual-use AI/defense/space computing IP. AI/ML is applied in specific research workflows (predictive analytics for cancer mutations, AI treatment prediction, computational fluid dynamics for aerosol drug design) but is not a core institutional platform. Governance is by an appointed Board of Visitors under Virginia state law, with Moody's assigning an Aa3 stable credit rating to VCU's Virginia revenue bonds reflecting strong financial position and revenue diversification.

Name

Virginia Commonwealth University

Legal name

Virginia Commonwealth University

Website

https://vcu.edu

Company type

Private

Founded year

1968

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Virginia Commonwealth University is a public research university in Richmond, VA, serving students across 200+ degree programs and operating the VCU Health academic medical system. It is an NSF top-50 public research university with $524M in research expenditures and active technology commercialization.

Ownership category

akta.pro rank

Product category

Higher Education and Academic Medicine

NAICS

Colleges, Universities, and Professional Schools (6113), Colleges, Universities, and Professional Schools (611310), Colleges, Universities, and Professional Schools (61131)

SIC

Services-Educational Services (8200)

akta.pro primary industry

Public Research Universities with Comprehensive Graduate & Professional Schools (EDAHAAAF)

akta.pro secondary industries

Public Research Universities with Engineering/Polytechnic Emphasis (EDAHAAAD), Business & Management Research Universities (EDAHABAE)

Keywords

• Public research university
• Undergraduate and graduate education
• Academic medical center
• Healthcare services
• Biomedical research

Headquarters

HQ city

Richmond

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Others

Revenue model

1. Tuition and Fees: Revenue from undergraduate and graduate tuition, with different rates for in-state and out-of-state students. Undergraduate in-state tuition was $12,850 in 2023-24 with additional fees of $3,383.
2. Research Grants and Contracts: Funding from federal agencies (NIH, NSF, etc.), state government, foundations, and industry partners. VCU reached $524 million in research expenditures and $568 million in funding.
3. Healthcare Services (VCU Health): Revenue from VCU Health system providing medical services through hospitals and clinics, including transplant procedures and specialty care.
4. Technology Licensing: Revenue from licensing university-developed technologies to commercial partners, such as spintronic semiconductor technologies licensed to Rocket One Inc.
5. State Appropriations: State funding from the Commonwealth of Virginia supporting public university operations.
6. Private Philanthropy: Donations and fundraising through the university development office supporting scholarships, facilities, and programs.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

Core offering

Virginia Commonwealth University is a public research university providing higher education through 200+ degree and certificate programs across undergraduate, graduate, and professional levels, integrated with faculty-led research opportunities. The university additionally operates VCU Health, an academic medical center delivering specialized clinical services, and conducts sponsored research producing licensable technologies in semiconductors, pharmaceuticals, and biomedical devices.

Product overview

Virginia Commonwealth University is a public research institution offering over 200 degree and certificate programs across multiple colleges and schools. The university's research portfolio includes life sciences (biomedical engineering, cancer research, pharmaceutical development), semiconductor/ nanomaterials technology (spintronic computing licensed to industry partners), healthcare innovations (medical devices, drug delivery systems), and computational tools (AI/ML for healthcare applications). VCU's technology transfer efforts commercialize university-developed innovations through licensing agreements with industry partners.

Differentiator

Problem solved

Functional benefit

Brands

• VCU Health: The academic health system of Virginia Commonwealth University, encompassing VCU Medical Center, MCV Physicians, and related healthcare facilities.
• VCU Rams
• VCU Health Hume-Lee Transplant Center

Products and services

• Undergraduate Degree Programs Over 200 undergraduate degree programs offered across multiple colleges and schools, covering arts, sciences, business, engineering, and health sciences. Designed for prospective and current undergraduate students seeking bachelor's degrees at a public research university.
• Graduate and Professional Degree Programs Master's, doctoral, and professional degree programs across graduate colleges and schools, serving students seeking advanced academic credentials and professional qualifications.
• VCU Online Learning Programs Online degree and certificate programs for remote students seeking higher education credentials without on-campus attendance.
• Continuing Education Continuing education programs through VCU's Office of Continuing and Professional Education serving adult learners and working professionals.
• VCU Health System Patient Care Academic medical center services provided through VCU Health including hospital care, specialty clinics, transplant services, cancer care, and clinical trials for patients across Virginia and the broader region.
• Adult Sickle Cell Disease Medical Home Program Coordinated multidisciplinary care program for adult sickle cell disease patients in Virginia, achieving a 10% reduction in readmission rates, decreased inpatient days by 1,096, and averting $2.465 million in charges.
• LGMD Centers of Excellence Care Coordinated multidisciplinary care for patients with limb-girdle muscular dystrophy through VCU Health's participation in the LGMD Centers of Excellence network.
• Joint Genomic Sequencing Services (NovaSeq X Plus with Virginia Tech) High-throughput genomic sequencing services using the Illumina NovaSeq X Plus instrument capable of generating up to 20 terabases of data per run, jointly operated with Virginia Tech and offered to Virginia researchers.

Quantifiable outcome

• Research expenditures doubled to $524 million in five years
• +5 more outcomes

Named customers6 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability6 records

Feature7 records

Partnerships

Eight partnerships are on record, tiered core, flagship and minor.

• Seattle Children's Research InstitutecoreStrategic or Co-development Partner · 22 May 2026Collaborative partnership in $3 million Gates Foundation-funded project developing affordable, noninvasive aerosol-based treatment for respiratory distress syndrome in newborns. VCU researchers lead the project with collaborators from Seattle Children's Research Institute.
• Rocket One Inc. (formerly Hoth Therapeutics)flagshipOEM/ Whitelabel/ Licensing Partner · 15 May 2026Rocket One acquired exclusive licensing rights to two spintronic semiconductor technologies developed at VCU: nanomagnetic matrix multiplier for AI acceleration and skyrmion-based spintronic memory for defense and space computing. Company rebranded from Hoth Therapeutics to focus on nanomagnetic AI chip technology for space and defense applications.
• Skil-CareminorStrategic or Co-development Partner · 12 May 2026VCU College of Engineering collaborating with Skil-Care's Clinical Innovation Partnership program on a fecal management flow positioning device originating from an ICU nurse.
• American Nuclear SocietyminorOthers · 6 May 2026American Nuclear Society honored Zeyun Wu with Untermyer & Cisler Reactor Technology Medal for contributions to advanced nuclear reactor designs.
• Speak FoundationcoreStrategic or Co-development Partner · 20 April 2026VCU Health participating in LGMD Centers of Excellence national network launched by Speak Foundation, joining University of Iowa Health Care, University of Florida College of Medicine, University of Minnesota, and University of Texas at San Antonio.
• Virginia TechflagshipStrategic or Co-development Partner · 2 April 2026Historic partnership between VCU and Virginia Tech to jointly purchase and operate the Illumina NovaSeq X Plus genomic sequencing instrument. First instance of a single piece of research instrumentation being jointly owned, managed, and operated by two independent universities in Virginia. Expected to reduce sequencing costs by 60% while accelerating breakthroughs in precision medicine and agricultural resilience.
• Policy Pathways, Inc.minorStrategic or Co-development Partner · 9 March 2026Partnership with Policy Pathways, a Richmond-based nonprofit, to offer the 2026 Summer Academy for Policy Leadership and Public Service for youth ages 15-25.
• United Lisbon Education HubminorStrategic or Co-development Partner · 17 October 2025International education partnership through Memorandum of Understanding aimed at fostering academic, cultural, and community-focused initiatives to enhance Lisbon's reputation as a global learning destination.

Scale indicators16 records

Recent moves6 records

Expansion highlights4 records

Regional players

• George Mason University: Virginia public research university with significant research expenditure growth and a focus on policy, biotech, and data sciences. Comparable as a Northern Virginia-based public R1 with overlapping STEM and health research programs and shared state-appropriated funding dynamics.
• University of Maryland, College Park: Mid-Atlantic public research university with comparable research expenditure scale and academic medical center adjacency. Comparable as a flagship state public R1 with engineering, life sciences, and tech transfer programs competing for similar federal research dollars.
• James Madison University: In-state Virginia public university that competes with VCU for Virginia-resident undergraduate students. Comparable as a Commonwealth-funded public institution targeting similar in-state applicant pools, though more undergraduate-focused and with a lower research intensity.

Broad incumbents

• University of Florida: Top-tier public research university with significantly larger research expenditures and academic medical center. Comparable for the research-driven model and recent scale-up of research funding, providing a benchmark for VCU's growth trajectory.

Direct peers

• Virginia Tech: Virginia's largest public research university and VCU's joint partner on the Illumina NovaSeq X Plus. Comparable as a public R1 university with major engineering, life sciences, and technology transfer activity serving the same Commonwealth constituency.
• University of Virginia: Virginia's flagship public research university and VCU's most direct in-state peer. Comparable as a comprehensive public research institution with a top-tier academic medical center, strong research funding, and similar student/patient populations in the Commonwealth of Virginia.
• University of North Carolina at Chapel Hill: Public research university with an academic medical center, large research portfolio, and state appropriations model structurally similar to VCU. Comparable as a Southeast public R1 with medical school, health system, and a comparable mix of NIH-funded research.
• University of Pittsburgh: Public research university whose medical center (UPMC) is a defining feature, with substantial NIH funding and technology transfer activity. Comparable to VCU for the medical-center-anchored research model and urban Pennsylvania/Virginia overlap in patient catchment.
• Rutgers University: Large public research university with a comprehensive academic medical center (RWJBarnabas partnership) operating in a state-funded model analogous to VCU. Comparable for research enterprise scale, urban campus profile, and health system integration.

Others

• Virginia Commonwealth University Health System (VCU Health): VCU's own academic medical center subsidiary, included as a peer reference for comparable academic medical centers such as UVA Health, UNC Health, and UPMC. Useful as an internal benchmark for the healthcare delivery arm.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/VCU
• YouTubeyoutube.com/c/virginiacommonwealthuniversity
• Facebookfacebook.com/22922516119
• LinkedInlinkedin.com/company/virginia-commonwealth-university
• Instagraminstagram.com/vcu

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries1 record

Funding overview

Funding rounds8 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Virginia Commonwealth University